Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
NorthStar Realty Finance Corp. (NYSE: NRF) shares closed up 20.22 percent on Wednesday with about 55 million shares traded. The stock hit a new 52-week high of $12.00 during intra-day trading. The move came after announcing that its board had unanimously voted to spin off its asset management business into a separately traded public company by the second quarter of next year. The spin-off will be considered a tax-free distribution.
Get more information on NorthStar Realty Finance Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/NRF
Emo Capital Corp. (OTCBB: NUVI) shares closed up 34.62 percent on Wednesday with about 12.8 million shares traded. The stock was one of the biggest gainers in the OTCBB market. The company announced the finalization of key ingredients to formulate the RED XL, which is our flagship natural male enhancement pill. RED XL utilizes a unique blend of all natural products to deliver increased sexual performance.
Get more information on Emo Capital Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/NUVI
CytRx Corporation (NASDAQ: CYTR) shares closed up 68.20 percent on Wednesday making it one of the biggest gainers on the NASDAQ. The stock traded nearly 32 million shares and hit a new 52-week high of $4.38 during intra-day trading. The big move came after highly statistically significant positive results from its global phase 2b clinical trial.
Get more information on CytRx Corporation and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CYTR
Opko Health, Inc. (NYSE: OPK) shares down 14.70 percent on Wednesday with about 17.6 million shares traded. The stock was one of the biggest decliners on the NYSE. The stock tumbled the most in five years after short seller Lakewood Capital Management said the stock is “grossly overvalued.” Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies.
Get more information on Opko Health, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/OPK
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
Leave a comment...